In silico-based vaccine design against Ebola virus glycoprotein

Ebola virus (EBOV) is one of the lethal viruses, causing more than 24 epidemic outbreaks to date. Despite having available molecular knowledge of this virus, no definite vaccine or other remedial agents have been developed yet for the management and avoidance of EBOV infections in humans. Disclosing...

Descripción completa

Detalles Bibliográficos
Autores principales: Dash, Raju, Das, Rasel, Junaid, Md, Akash, Md Forhad Chowdhury, Islam, Ashekul, Hosen, SM Zahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367765/
https://www.ncbi.nlm.nih.gov/pubmed/28356762
http://dx.doi.org/10.2147/AABC.S115859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367765/
https://www.ncbi.nlm.nih.gov/pubmed/28356762
http://dx.doi.org/10.2147/AABC.S115859

Ejemplares similares